US FDA contemplates collection of pharmacogenomic data
Nature Biotechnology 2003 June; 21(6): 590
Showing items related by title, author, creator and subject.
United States. Food and Drug Administration [FDA]. Center for Drug Evaluation and Research [CDER]; Center for Biologics Evaluation and Research [CBER]; Center for Devices and Radiological Health [CDRH] (2003-11)